Treatment with 5α-reductase inhibitors improves disease-specific survival following a diagnosis of bladder cancer, suggests a recent study. On the other hand, α-blockers do not appear to improve bladder cancer survival.
Host factors, such as tumour (size, complexity) and patient characteristics (comorbidities, advanced age, abnormal body mass index [BMI], chronic kidney disease [CKD], prior abdominal surgery), affect the outcomes of robotic partial nephrectomy (RPN), according to the results of a meta-analysis.
Corticosteroids may protect renal function and reduce proteinuria in patients with immunoglobulin A nephropathy (IgAN), a chronic glomerular disease that may gradually progress to end-stage renal disease (ESRD), according to a meta-analysis.
The phosphodiesterase type 5 inhibitor tadalafil significantly improved the erectile function of patients receiving the 5-alpha reductase inhibitor (5-α RI) dutasteride for the management of bladder outlet obstruction, according to a Turkish study.